This inventor holds 2 USPTO granted patents. Top assignees: Xoma (US) LLC, Xoma Technology Ltd.. Active years: 2013-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2015
Title: Ahmet Gül: Innovator in Uveitis Treatment
Introduction
Ahmet Gül is a prominent inventor based in Istanbul, Turkey. He has made significant contributions to the field of medical treatments, particularly focusing on uveitis. With a total of 2 patents, his work has the potential to impact many lives.
Latest Patents
Ahmet Gül's latest patents include innovative methods for the treatment of uveitis using IL-1β binding antibodies. These patents disclose methods and materials for inhibiting uveitis in a subject, including treatment refractory uveitis, through the use of anti-IL-1β binding molecules. His research aims to provide effective solutions for patients suffering from this condition.
Career Highlights
Throughout his career, Ahmet Gül has worked with notable companies such as Xoma LLC and Xoma Technology Ltd. His experience in these organizations has allowed him to develop and refine his innovative approaches to medical treatments.
Collaborations
Ahmet Gül has collaborated with various professionals in his field, including his coworker Alan M Solinger. These partnerships have contributed to the advancement of his research and the development of his patents.
Conclusion
Ahmet Gül's contributions to the treatment of uveitis through his patented methods highlight his role as an influential inventor in the medical field. His work continues to pave the way for advancements in patient care and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile